Oxford coronavirus vaccine safe and promising, according to early human trial results published in the Lancet

A University of Oxford group and the British-Swedish pharmaceutical company AstraZeneca reported Monday that their coronavirus vaccine candidate, on which the U.S. and European governments have placed substantial bets, was shown in early-stage human trials to be safe and to stimulate a strong immune response.

Publisher: Washington Post | Author: William Booth

TAGS
human trials and vaccine
DATE PUBLISHED
2020-07-20 (Modified: 2021-05-18)

STAR RATING
[Total: 0   Average: 0/5]
VIEW RESOURCE
https://www.washingtonpost.com/world/europe/oxford-coronavirus-vaccine-phase-1-lancet/2020/07/20/12fbbc92-c857-11ea-a825-8722004e4150_story.html

Leave a Reply